The treatment, the first of its kind, was approved by the Food and Drug Administration on Thursday. “Our baby was born deaf, and now he can hear,” said one parent.
Category: Clinical Trials
-
New Gene Therapy Enables Children With a Rare Form of Deafness to Hear
The New York Times – Business: -
Two Drugs Stir Hope for Treatment of Deadly Pancreatic Cancer
The New York Times – Business:In separate small clinical trials, two treatments showed promise that they could help patients with one of the most dire diagnoses in oncology.
-
A Cancer Detection Test Fails in Major Study
The New York Times – Business:A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in later stages of the disease.
-
U.S. Health Officials Defend Rejection of Moderna’s Flu Vaccine
The New York Times – Business:The F.D.A.’s refusal to examine the company’s mRNA shot drew widespread criticism from doctors and was divisive within the agency.
-
New Eli Lilly Drug Retatrutide Brought Major Weight Loss in Trial
The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug.
-
Ozempic Drug Fails to Quell Alzheimer’s in Novo Nordisk Trials
The studies were a significant setback for the optimistic view that semaglutide and other GLP-1 drugs could help prevent a number of brain diseases.
-
Study Finds Evidence That Text-Based Therapy Eases Depression
A large-scale randomized trial of texting therapy concluded that its outcomes were as good as video sessions in treating depression.
-
F.D.A. Moves to Speed Approvals for Cheaper Copycat Drugs
The agency announced moves to cut regulatory obstacles for the makers of biosimilar drugs, which are akin to generics and may help lower drug costs.
-
How Private Equity Oversees the Ethics of Drug Research
Many drug trials are vetted by companies with ties to the drugmakers, raising concerns about conflicts of interest and patient safety.
-
Trump Weighs Crackdown on Medicines From China
Behind the scenes, major pharmaceutical companies and Trump-tied billionaires are furiously lobbying in opposite directions over proposed anti-China measures.
-
Pill Causes Major Weight Loss in Eli Lilly Trial’s Results
The company said it planned to seek Food and Drug Administration approval for the drug, orforglipron, before the end of the year.
-
Promise of Victory Over H.I.V. Fades as U.S. Withdraws Support
A new drug that gives almost complete protection against the virus was to be administered across Africa this year. Now, much of the funding for that effort is gone.